참고문헌
- Drenth JP, Chrispijn M, Bergmann C. Congenital fibrocystic liver diseases. Best Pract Res Clin Gastroenterol 2010; 4:573-584.
- Kerkar N, Norton K, Suchy FJ. The hepatic fibrocystic diseases. Clin Liver Dis 2006;10:55-71. https://doi.org/10.1016/j.cld.2005.10.003
- Desmet VJ. What is congenital hepatic fibrosis? Histopathology 1992;20:465-477.
- Brancatelli G, Federle MP, Vilgrain V, Vullierme MP, Marin D, Lagalla R. Fibropolycystic liver disease: CT and MR imaging findings. Radiographics 2005;25:659-670. https://doi.org/10.1148/rg.253045114
- Caremani M, Vincenti A, Benci A, Sassoli S, Tacconi D. Ecographic epidemiology of non-parasitic hepatic cysts. J Clin Ultrasound 1993;21:115-118. https://doi.org/10.1002/jcu.1870210207
- Reid-Lombardo KM, Khan S, Sclabas G. Hepatic cysts and liver abscess. Surg Clin North Am 2010;90:679-697. https://doi.org/10.1016/j.suc.2010.04.004
- Redston MS, Wanless IR. The hepatic von Meyenburg complex: prevalence and association with hepatic and renal cysts among 2843 autopsies [corrected]. Mod Pathol 1996; 9:233-237.
- Guy F, Cognet F, Dranssart M, Cercueil JP, Conciatori L, KrausE D. Caroli's disease: magnetic resonance imaging features. Eur Radiol 2002;12:2730-2736.
- Todani T, Watanabe Y, Narusue M, Tabuchi K, Okajima K. Congenital bile duct cysts: classification, operative procedures, and review of thirty-seven cases including cancer arising from choledochal cyst. Am J Surg 1977;134: 263-269. https://doi.org/10.1016/0002-9610(77)90359-2
- Onori P, Franchitto A, Mancinelli R, et al. Polycystic liver diseases. Dig Liver Dis 2010;42:261-271. https://doi.org/10.1016/j.dld.2010.01.006
- Van Keimpema L, de Man RA, Drenth JP. Somatostatin analogues reduce liver volume in polycystic liver disease. Gut 2008;57:1338-1339. https://doi.org/10.1136/gut.2008.155721
- Torres VE, Boletta A, Chapman A, et al. Prospects for mTOR inhibitor use in patients with polycystic kidney disease and hamartomatous diseases. Clin J Am Soc Nephrol 2010;5:1312-1329. https://doi.org/10.2215/CJN.01360210